ESSA Pharma Inc. Stock News

ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) Investment analysts at Jefferies Financial Group dropped their FY2022 EPS estimates for shares of ESSA Pharma in a report released on Wednesday, November 24th. Jefferies Financial Group analyst M. Raycroft now forecasts that the company will post earnings per share of ($1.12) for the year, down from their previous []

Credit Suisse AG bought a new stake in ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) during the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 12,226 shares of the companys stock, valued at approximately $348,000. Several other large investors have also recently modified their holdings of the company. Goldman Sachs Group Inc. boosted its stake in []

Northern Trust Corp boosted its holdings in ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) by 140.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 28,957 shares of the companys stock after purchasing an additional 16,904 shares during the quarter. Northern Trust Corp owned approximately 0.07% [] The post Northern Trust Corp Acquires 16,904 Shares of ESSA Pharma Inc. (NASDAQ:EPIX) appeared first on ETF Daily News .

ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) Investment analysts at Jefferies Financial Group issued their Q1 2022 EPS estimates for ESSA Pharma in a research report issued on Wednesday, November 24th. Jefferies Financial Group analyst M. Raycroft forecasts that the company will post earnings of ($0.24) per share for the quarter. Jefferies Financial Group also issued []

Morgan Stanley reduced its stake in shares of ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) by 13.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 496,809 shares of the companys stock after selling 76,158 shares during the quarter. Morgan Stanleys holdings []

Wall Street analysts predict that ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) will announce earnings of ($0.29) per share for the current quarter, Zacks Investment Research reports. Zero analysts have provided estimates for ESSA Pharmas earnings, with the lowest EPS estimate coming in at ($0.31) and the highest estimate coming in at ($0.27). ESSA Pharma reported earnings []

ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) released its earnings results on Wednesday. The company reported ($0.20) earnings per share (EPS) for the quarter, beating analysts consensus estimates of ($0.23) by $0.03, MarketWatch Earnings reports. NASDAQ EPIX traded down $0.34 during trading on Friday, reaching $12.66. 53 shares of the companys stock were exchanged, compared to its average []

VANCOUVER, Canada and HOUSTON, Texas, Nov. 18, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported

Equities research analysts expect that ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) will announce ($0.23) earnings per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for ESSA Pharmas earnings. The highest EPS estimate is ($0.18) and the lowest is ($0.26). ESSA Pharma posted earnings of ($0.17) per share during the same []

ESSA Pharma developed a novel mode of action drug, EPI-7386, for the treatment of metastatic castrate-resistant prostate cancer. Pre-clinical and early Ph 1 results are promising. ESSA's share price c

IRVING, Texas, and HOUSTON, and VANCOUVER, BC, Oct. 7, 2021 /PRNewswire/ --  Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, an

VANCOUVER, Canada and HOUSTON, Texas, Aug. 31, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel the

HOUSTON, Texas and VANCOUVER, Canada, Aug. 16, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therap

HOUSTON, Texas and VANCOUVER, Canada, May 25, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therap